Active Pediatric Hematology & Oncology Clinical Trials
Pediatric Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Title: An Open-Label Treatment Protocol for the Use of Voraxaze as Adjunctive Treatment for Patients Experiencing or at Risk of Methotrexate Toxicity
Decscription: Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
Investigator: Louise Lo, MD
Eligibility: Pediactric patients who have received high-dose chemotherapy with methotrexate
Status: Active and open to enrollment
Contact: Chanel Durley, 415-600-3246,
Email: DurleyC@cpmcri.org about Study Voraxaze
Title: California Childhood Leukemia Study
Decscription:
Investigator: Louise Lo, MD
Eligibility: Children under the age of 15 diagnosed with leukemia, as well as biological parents
Status: Active and open to enrollment
Contact: Chanel Durley, 415-600-3246,
DurleyC@cpmcri.org about Study CCLS
- updated March 2012
Back to top